Aya Gold & Silver Reports High-Grade Silver Results at Zgounder

(TSX:AYA),(OTC US:AYASF),(Other OTC:AYASF), MONTREAL, Dec. 09, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation“) is pleased to announce additional high-grade silver drill results from its at-depth drill exploration program at the Zgounder Silver Mine in the Kingdom of Morocco. Highlights (all intersections are in core lengths) […]

G-III Apparel Group, Ltd. Reports Third Quarter Fiscal 2026 Results and Updates Fiscal 2026 Outlook; Initiates First Ever Quarterly Dividend Program

(NASDAQ:GIII), Net Income Per Diluted Share of $1.84 and Non-GAAP Net Income Per Diluted Share of $1.90 for the Third Quarter, Both Exceeding Guidance Net Sales of $988.6 Million for the Third Quarter Raises GAAP and Non-GAAP Net Income Per Diluted Share Guidance Maintains Strong Cash and Availability Position Introduces First Ever Quarterly Dividend of

DAVE & BUSTER’S LAUNCHES LIMITED-EDITION “CLAW PURSE,” A PURSE DESIGNED TO LOOK LIKE A CLAW MACHINE IN COLLABORATION WITH CHAIN

The Ultimate Holiday Collectible: A Claw-Machine-Inspired Purse Celebrating the Nationwide Rollout of Dave & Buster's Human Crane Machine Dave & Buster's is leveling up holiday gifting with the debut of the Claw Purse, a limited-edition purse designed by Chain. The Claw Purse is inspired by one of the brand's most iconic games – the claw

Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance

(NasdaqGM:LGND), Introduces 2026 full year revenue guidance of $245 million to $285 million, an approximately 15% increase in core revenue growth over 2025, royalty revenue of $200 to $225 million, a 40% increase over 20251, and core adjusted earnings per diluted share of $8.00 to $9.002 Increases 5-year royalty receipt outlook driven by Filspari, Ohtuvayre,

Aetherflux Announces Orbital Data Center; Targets Q1 2027

Solar-powered, artificial intelligence compute satellite bypasses 5-8 year terrestrial energy delays Today, Aetherflux announced a Q1 2027 target for its first orbital data center satellite, which leverages solar power in space to address the massive energy needs for artificial intelligence. The project, dubbed “Galactic Brain”, offers a bypass to the current five-to-eight year time horizon

CRML Executes Term-Sheet for 50/50 Joint Venture With EU and NATO Member, Romania, Creating a Fully Integrated Mine-to-Processing Supply Chain for Long-Term Security for the European Manufacturing & National Security Sectors

(NasdaqGM:CRML), NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) — Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp.” or the “Company”), a leading critical minerals mining company, today announced that it has executed the Term-Sheet for creating a 50%-50% joint venture (JV) between CRML and Fabrica de Prelucrare a Concentratelor de Uraniu S.R.L. (FPCU) of Romania,

Safe Harbor Launches New Payroll Cashflow Solution and Announces Major Banking Win with Canopy HR

(NASDAQ:SHFS), DENVER, Dec. 09, 2025 (GLOBE NEWSWIRE) — SHF Holdings, Inc., d/b/a Safe Harbor Financial (“Safe Harbor” or the “Company”) (NASDAQ: SHFS), a provider of banking, lending, and financial services to the legal cannabis industry, announced that Canopy HR–one of the largest payroll-service providers in the cannabis sector–selected Safe Harbor to support nearly all of

Senti Bio Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for SENTI-202 in the Treatment of Adults with Relapsed or Refractory Acute Myeloid Leukemia

(NASDAQ:SNTI), RMAT designation indicates that SENTI-202 has the potential to address unmet medical needs for patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) based on preliminary clinical evidence, and offers benefits of FDA working closely with Senti Bio to provide guidance and advice on generating the data needed to support approval of the product in

Senti Bio Announces Updated SENTI-202 Clinical Data from Ongoing Phase 1 Trial in Relapsed or Refractory Acute Myeloid Leukemia Patients, Demonstrating Deep, MRD Negative, Durable Complete Remissions and a Favorable Safety Profile

(NASDAQ:SNTI), ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high efficacy: 50% ORR and 42% CR/CRh (100% of CRs and 83% of all responses were MRD negative) at RP2D, 7.6 months median duration of composite Complete Remission across all patients, and a favorable safety

Ollie’s Bargain Outlet Holdings, Inc. Announces Third Quarter Fiscal 2025 Results

(NasdaqGM:OLLI), Store Openings, Sales, and Earnings Ahead of Expectations Net Sales Increased 18.6% and Earnings Per Share Increased 29.3% Raising Fiscal 2025 Sales and Earnings Outlook HARRISBURG, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) — Ollie's Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) today announced financial results for the third quarter ended November 1, 2025.

Scroll to Top